A_DT Wild-Type_NP Porcine_NP Encephalomyocarditis_NP Virus_NP Containing_NP a_DT Short_JJ Poly(C)_NP Tract_NP Is_VBZ Pathogenic_JJ to_TO Mice_NNS ,_, Pigs_NP ,_, and_CC Cynomolgus_NP Macaques_NP Previous_JJ studies_NNS using_VBG wild-type_NN Encephalomyocarditis_NN virus_NN (_( EMCV_NP )_) and_CC Mengo_NP virus_NN ,_, which_WDT have_VBP long_RB poly(C)_JJ tracts_NNS (_( 61_CD to_TO 146_CD C_NP 's_POS )_) at_IN the_DT 5_CD '_POS nontranslated_JJ region_NN of_IN the_DT genome_NN ,_, and_CC variants_NNS of_IN these_DT viruses_NNS genetically_RB engineered_VBN to_TO truncate_VB or_CC substitute_VB the_DT poly(C)_JJ tracts_NNS have_VBP produced_VBN conflicting_JJ data_NNS on_IN the_DT role_NN of_IN the_DT poly(C)_JJ tract_NN in_IN the_DT virulence_NN of_IN these_DT viruses_NNS ._SENT Analysis_NN of_IN the_DT nucleotide_NN sequence_NN of_IN an_DT EMCV_NP strain_NN isolated_VBN from_IN an_DT aborted_JJ swine_NN fetus_NN (_( EMCV_NP 30/87_CD )_) revealed_VBD that_IN the_DT virus_NN had_VBD a_DT poly(C)_JJ tract_NN that_WDT was_VBD 7-_CD to_TO 10-fold_NN shorter_JJR than_IN the_DT poly(C)_JJ tracts_NNS of_IN other_JJ EMCV_NP strains_NNS and_CC 4-fold_JJ shorter_JJR than_IN that_DT of_IN Mengo_NP virus_NN ._SENT Subsequently_RB ,_, we_PP investigated_VBD the_DT virulence_NN and_CC pathogenesis_NN of_IN this_DT naturally_RB occurring_VBG short-poly(C)-tract-containing_JJ virus_NN in_IN rodents_NNS ,_, pigs_NNS ,_, and_CC nonhuman_NN primates_NNS ._SENT Infection_NN of_IN C57BL/6_NP mice_NNS ,_, pigs_NNS ,_, and_CC cynomolgus_NN macaques_NNS resulted_VBN in_IN similar_JJ EMCV_NP 30/87_CD pathogenesis_NN ,_, with_IN the_DT heart_NN and_CC brain_NN as_IN the_DT primary_JJ sites_NNS of_IN infections_NNS in_IN all_DT three_CD animals_NNS ,_, but_CC with_IN different_JJ disease_NN phenotypes_NNS ._SENT Sixteen_CD percent_NN of_IN EMCV_NP 30/87-infected_JJ pigs_NNS developed_VBD acute_JJ fatal_JJ cardiac_JJ failure_NN ,_, whereas_IN the_DT rest_NN of_IN the_DT pigs_NNS were_VBD overtly_RB asymptomatic_JJ for_IN as_RB long_JJ as_IN 90_CD days_NNS postinfection_NN (_( p.i._NP )_) ,_, despite_IN extensive_JJ myocardial_JJ and_CC central_JJ nervous_JJ system_NN (_( CNS_NP )_) pathological_JJ changes_NNS ._SENT In_IN contrast_NN ,_, mice_NNS infected_VBN with_IN >=4_NP PFU_NP of_IN EMCV_NP 30/87_CD developed_VBD acute_JJ encephalitis_NN that_WDT resulted_VBD in_IN the_DT death_NN of_IN all_DT animals_NNS (_( n_NN =_SYM 25_CD )_) between_IN days_NNS 2_CD and_CC 7_CD p.i._JJ EMCV_NP 30/87-infected_JJ macaques_NNS remained_VBD overtly_RB asymptomatic_JJ for_IN 45_CD days_NNS ,_, despite_IN extensive_JJ myocardial_JJ and_CC CNS_NP pathological_JJ changes_NNS and_CC viral_JJ persistence_NN in_IN more_JJR than_IN 50_CD %_NN of_IN the_DT animals_NNS ._SENT The_DT short_JJ poly(C)_NN tract_NN in_IN EMCV_NP 30/87_CD (_( CUC5UC8_NP )_) was_VBD comparable_JJ to_TO that_DT of_IN strain_NN 2887A/91_JJ (_( C10UCUC3UC10_NP )_) ,_, another_DT recent_JJ porcine_JJ isolate_NN ._SENT Encephalomyocarditis_NN virus_NN (_( EMCV_NP )_) is_VBZ a_DT picornavirus_NN belonging_VBG to_TO the_DT Cardiovirus_NP genus_NN that_WDT infects_VBZ many_JJ animal_NN species_NNS including_VBG pigs_NNS ,_, rodents_NNS ,_, cattle_NNS ,_, elephants_NNS ,_, raccoons_NNS ,_, marsupials_NNS ,_, baboons_NNS ,_, macaques_NNS ,_, chimpanzees_NNS ,_, and_CC humans_NNS ._SENT Rats_NNS and_CC mice_NNS are_VBP the_DT natural_JJ hosts_NNS of_IN the_DT virus_NN ,_, but_CC pigs_NNS are_VBP the_DT most_RBS commonly_RB and_CC severely_RB infected_VBN domestic_JJ animals_NNS ._SENT EMCV_NP strains_NNS have_VBP been_VBN isolated_VBN from_IN primates_NNS ,_, pigs_NNS ,_, and_CC rodents_NNS ._SENT EMCV_NP Rueckert_NP (_( EMCV_NP R/45_NP )_) ,_, the_DT prototype_NN strain_NN ,_, was_VBD isolated_VBN from_IN a_DT 5-year-old_JJ chimpanzee_NN that_WDT suffered_VBD acute_JJ fatal_JJ myocarditis_NN in_IN 1945_CD ,_, whereas_IN EMC-M/58_NP virus_NN was_VBD isolated_VBN from_IN a_DT naturally_RB infected_JJ domestic_JJ pig_NN suffering_NN from_IN severe_JJ myocarditis_NN ._SENT A_DT number_NN of_IN EMC-M/58_NP variants_NNS ,_, including_VBG EMC-D/58_NP ,_, EMC-B/58_NP ,_, PV2/58_NP ,_, and_CC PV21/58_NP ,_, were_VBD generated_VBN in_IN laboratories_NNS and_CC used_VBN to_TO study_VB the_DT pathogenesis_NN of_IN viral_JJ diabetes_NN ._SENT Mengo_NP virus_NN ,_, another_DT cardiovirus_NN that_WDT shares_VBZ the_DT same_JJ serotype_NN as_IN EMCV_NP ,_, was_VBD isolated_VBN from_IN the_DT cerebrospinal_JJ fluid_NN of_IN a_DT paralyzed_JJ rhesus_NN macaque_NN in_IN 1948_CD ._SENT EMCV_NP 30/87_CD and_CC 2887A/91_JJ are_VBP more_RBR recent_JJ EMCV_NP isolates_NNS obtained_VBN from_IN aborted_JJ swine_NN fetuses_NNS in_IN the_DT United_NP States_NPS and_CC Belgium_NP ,_, respectively_RB ,_, following_VBG natural_JJ EMCV_NP outbreaks_NNS in_IN domestic_JJ pigs_NNS ._SENT Nucleotide_NN sequencing_VBG of_IN most_JJS EMCV_NP strains_NNS and_CC Mengo_NP virus_NN has_VBZ identified_VBN a_DT poly(C)_JJ tract_NN ,_, consisting_VBG of_IN 61_CD to_TO 146_CD cytosine_NN residues_NNS (_( C61_JJ to_TO C146_NP )_) ,_, occasionally_RB interrupted_VBN by_IN 1_CD to_TO 3_CD uridine_NN residues_NNS ,_, located_VBN at_IN the_DT 5_CD '_POS nontranslated_JJ region_NN (_( NTR_NP )_) of_IN the_DT positive-sense_JJ RNA_NP genome_NN ._SENT Studies_NNS to_TO determine_VB the_DT role_NN of_IN the_DT poly(C)_JJ tract_NN in_IN virus_NN replication_NN ,_, virulence_NN ,_, and_CC host_NN range_NN have_VBP produced_VBN conflicting_JJ findings_NNS ._SENT For_IN instance_NN ,_, in_IN earlier_JJR studies_NNS ,_, truncation_NN of_IN the_DT poly(C)_JJ tract_NN of_IN Mengo_NP virus_NN M/48_NP (_( from_IN C44UC10_NP to_TO C8-_NP or_CC C13UC10_NP )_) attenuated_VBN the_DT virus_NN in_IN mice_NNS ,_, resulting_VBG in_IN lower_JJR virus_NN titers_NNS in_IN the_DT brain_NN and_CC development_NN of_IN milder_JJR meningoencephalitis_NN ._SENT However_RB ,_, later_JJR ,_, more-extensive_JJ experiments_NNS using_VBG a_DT number_NN of_IN inbred_JJ strains_NNS of_IN mice_NNS demonstrated_VBD that_IN both_DT short-_NN and_CC long-poly(C)-tract_NN variants_NNS of_IN Mengo_NP virus_NN M/48_NP were_VBD highly_RB virulent_JJ in_IN newborn_JJ mice_NNS of_IN any_DT strain_NN ._SENT Studies_NNS using_VBG both_DT EMCV_NP R/45_NP and_CC EMCV_NP PV2/58_NP demonstrated_VBD no_DT correlation_NN between_IN the_DT length_NN of_IN the_DT poly(C)_JJ tract_NN and_CC virulence_NN ._SENT Truncation_NN of_IN the_DT poly(C)_JJ tract_NN in_IN EMCV_NP R/45_NP from_IN C115UC3UC10_NP to_TO C4_NP ,_, C9_NP ,_, or_CC C20_NP produced_VBD only_RB slight_JJ decreases_NNS in_IN virulence_NN among_IN 12-week-old_JJ SJL_NP mice_NNS ._SENT Strain_NP PV2/58_NP (_( containing_VBG 118_CD C_NP 's_POS )_) was_VBD cloned_VBN ,_, and_CC three_CD viruses_NNS with_IN different_JJ lengths_NNS of_IN the_DT poly(C)_JJ tract_NN were_VBD generated_VBN ;_: rPV2/dT_NP had_VBD the_DT poly(C)_JJ tract_NN replaced_VBN by_IN a_DT poly(U)_JJ tract_NN ,_, rPV2/C20_NN had_VBD the_DT poly(C)_JJ tract_NN replaced_VBN with_IN 20_CD C_NP 's_POS ,_, and_CC rPV2/ran_NP had_VBD the_DT poly(C)_JJ tract_NN replaced_VBN with_IN a_DT random_JJ sequence_NN of_IN 238_CD nucleotides_NNS ._SENT Infection_NN of_IN mice_NNS with_IN either_DT wild-type_NP PV2/58_NP ,_, rPV2/dT_NP ,_, rPV2/C20_NN ,_, or_CC rPV2/ran_NP resulted_VBD in_IN insignificantly_RB higher_JJR virus_NN loads_NNS and_CC degrees_NNS of_IN pathological_JJ lesions_NNS in_IN mice_NNS infected_VBN with_IN wild-type_NP PV2/58_NP than_IN in_IN mice_NNS infected_VBN with_IN recombinant_JJ viruses_NNS ,_, suggesting_VBG that_IN the_DT poly(C)_JJ tract_NN was_VBD not_RB essential_JJ for_IN virulence_NN in_IN mice_NNS ._SENT Another_DT interesting_JJ aspect_NN of_IN EMCV_NP pathogenesis_NN is_VBZ the_DT ability_NN of_IN these_DT viruses_NNS to_TO cause_VB interspecies_NNS infections_NNS ._SENT EMCV_NP outbreaks_NNS in_IN zoos_NNS in_IN Australia_NP and_CC the_DT United_NP States_NPS have_VBP involved_VBN multiple_JJ animal_NN species_NNS including_VBG lemurs_NNS ,_, squirrels_NNS ,_, macaques_NNS ,_, mandrills_NNS ,_, chimpanzees_NNS ,_, hippopotami_NNS ,_, kangaroos_NNS ,_, and_CC possibly_RB humans_NNS ._SENT The_DT few_JJ documented_VBN cases_NNS of_IN EMCV_NP infection_NN in_IN humans_NNS have_VBP been_VBN associated_VBN with_IN fever_NN ,_, neck_NN stiffness_NN ,_, lethargy_NN ,_, delirium_NN ,_, headaches_NNS ,_, or_CC vomiting_NN ._SENT In_IN Germany_NP ,_, strains_NNS of_IN the_DT virus_NN have_VBP been_VBN isolated_VBN from_IN children_NNS suffering_VBG from_IN meningitis_NN and_CC encephalitis_NN ,_, but_CC no_DT causal_JJ relationship_NN between_IN EMCV_NP and_CC the_DT symptoms_NNS has_VBZ been_VBN demonstrated_VBN ._SENT There_EX is_VBZ renewed_JJ interest_NN in_IN pig-to-human_NN zoonotic_JJ viruses_NNS because_IN of_IN advances_NNS in_IN xenotransplantation_NN as_IN a_DT means_NN of_IN overcoming_VBG the_DT acute_JJ shortage_NN of_IN transplantation_NN tissues_NNS and_CC organs_NNS for_IN humans_NNS ._SENT Porcine_JJ cells_NNS ,_, tissues_NNS ,_, and_CC organs_NNS are_VBP the_DT primary_JJ animal_NN tissues_NNS being_VBG considered_VBN for_IN human_JJ transplantation_NN because_IN of_IN the_DT similarities_NNS in_IN anatomical_JJ and_CC physiological_JJ features_NNS between_IN humans_NNS and_CC pigs_NNS ,_, the_DT availability_NN of_IN the_DT species_NN ,_, and_CC the_DT relative_JJ ease_NN of_IN breeding_VBG pigs_NNS ._SENT It_PP has_VBZ recently_RB been_VBN demonstrated_VBN that_DT infection_NN of_IN 5-week-old_JJ pigs_NNS with_IN EMCV_NP 30/87_CD resulted_VBD in_IN the_DT deaths_NNS of_IN 16_CD %_NN of_IN the_DT pigs_NNS 2_CD to_TO 3_CD days_NNS after_IN infection_NN from_IN acute_JJ myocarditis_NN ,_, characterized_VBN by_IN extensive_JJ lysis_NN of_IN sarcoplasm_NN ,_, cellular_JJ degeneration_NN ,_, and_CC mineralization_NN in_IN the_DT myocardium_NN ._SENT The_DT rest_NN of_IN the_DT infected_JJ pigs_NNS (_( 84_CD %_NN )_) did_VBD not_RB develop_VB clinical_JJ illness_NN but_CC showed_VBD virus_NN persistence_NN for_IN as_RB long_JJ as_IN 90_CD days_NNS in_IN cardiomyocytes_NNS and_CC central_JJ nervous_JJ system_NN (_( CNS_NP )_) cells_NNS ,_, which_WDT was_VBD associated_VBN with_IN extensive_JJ apoptosis_NN and_CC viral_JJ antigen_NN expression_NN ._SENT More_RBR importantly_RB ,_, EMCV_NP 30/87_CD productively_RB infected_VBN primary_JJ human_JJ cardiomyocytes_NNS ,_, resulting_VBG in_IN production_NN of_IN 100_CD to_TO 1,000_CD PFU_NN of_IN infectious_JJ virus_NN per_IN cell_NN within_IN 6_CD h._NN In_IN the_DT present_JJ study_NN ,_, we_PP demonstrate_VBP from_IN the_DT nucleotide_NN sequence_NN that_IN EMCV_NP 30/87_CD has_VBZ the_DT shortest_JJS poly(C)_NN tract_NN of_IN any_DT naturally_RB occurring_VBG EMCV_NP strain_NN ,_, and_CC we_PP determine_VBP its_PP$ virulence_NN and_CC pathogenesis_NN in_IN rodents_NNS ,_, pigs_NNS ,_, and_CC nonhuman_NN primates_NNS ._SENT Viruses_NNS ._SENT |_SYM An_DT EMCV_NP strain_NN isolated_VBN from_IN naturally_RB infected_VBN pigs_NNS in_IN Minnesota_NP in_IN 1987_CD (_( EMCV_NP 30/87_CD )_) was_VBD used_VBN in_IN all_PDT our_PP$ experiments_NNS ._SENT The_DT virus_NN was_VBD amplified_VBN by_IN infection_NN of_IN HeLa_NP cells_NNS ,_, which_WDT were_VBD maintained_VBN in_IN RPMI_NP 1640_CD medium_NN supplemented_VBN with_IN 5_CD %_NN fetal_JJ bovine_JJ serum_NN ,_, l-glutamine_NN ,_, antibiotics_NNS ,_, and_CC antimycotics_NNS ._SENT The_DT nucleotide_NN sequences_NNS of_IN EMCV_NP 30/87_CD were_VBD compared_VBN to_TO the_DT sequences_NNS of_IN Mengo_NP virus_NN M/48_NP and_CC EMCV_NP strains_NNS R/45_NP ,_, EMC-B/58_NP ,_, EMC-D/58_NP ,_, PV2/58_NP ,_, PV21/58_NP ,_, and_CC 2887A/91_JJ ._SENT The_DT year_NN of_IN the_DT parent_NN isolate_NN has_VBZ been_VBN added_VBN to_TO the_DT designation_NN of_IN each_DT of_IN these_DT strains_NNS ,_, and_CC the_DT same_JJ year_NN is_VBZ given_VBN to_TO laboratory_NN variants_NNS of_IN a_DT particular_JJ isolate_NN (_( e.g._FW ,_, EMC-B/58_NP ,_, EMC-D/58_NP ,_, PV2/58_NP ,_, PV21/58_NP )_) ._SENT Nucleotide_NN sequencing_VBG of_IN EMCV_NP 30/87_CD ._SENT |_SYM EMCV_NP 30/87_CD RNA_NP from_IN virus-infected_JJ HeLa_NP cells_NNS was_VBD extracted_VBN by_IN using_VBG a_DT guanidinium_NN thiocyanate-phenol-chloroform_NN reagent_NN (_( TRIzol_NP ;_: Invitrogen_NP ,_, San_NP Diego_NP ,_, Calif._NP )_) ._SENT The_DT RNA_NP ,_, derived_VBN both_CC from_IN a_DT mixed_JJ population_NN of_IN low-passage-number_JJ EMCV_NP 30_CD and_CC from_IN a_DT plaque-purified_JJ clone_NN ,_, was_VBD reverse_RB transcribed_VBN using_VBG oligo(dT)_JJ primers_NNS with_IN Superscript_JJ II_NP reverse_NN transcriptase_NN (_( Invitrogen_NP )_) at_IN 42C_JJ for_IN 50_CD min_NN ._SENT Initial_JJ primers_NNS for_IN amplification_NN of_IN 800_CD bp_NN at_IN the_DT 5_CD '_POS untranslated_JJ end_NN of_IN the_DT EMCV_NP 30/87_CD sequence_NN were_VBD designed_VBN by_IN using_VBG EMCV_NP strain_NN R/45_NP (_( GenBank_NP accession_NN number_NN )_) ._SENT Subsequent_JJ primers_NNS designed_VBN from_IN EMCV_NP 30/87_CD sequences_NNS were_VBD used_VBN to_TO complete_VB the_DT rest_NN of_IN the_DT genome_NN ._SENT After_IN reverse_JJ transcription_NN ,_, PCR_NP was_VBD performed_VBN using_VBG 10_CD mul_NN of_IN the_DT cDNA_NN ._SENT For_IN PCR_NP ,_, the_DT cDNA_NN was_VBD denatured_VBN at_IN 94C_NN for_IN 5_CD min_NN ,_, followed_VBN by_IN 30_CD cycles_NNS of_IN denaturation_NN (_( at_IN 94C_NN for_IN 1_CD min_NN )_) ,_, annealing_VBG (_( at_IN 60C_JJ for_IN 1_CD min_NN )_) ,_, and_CC elongation_NN (_( at_IN 72C_NP for_IN 1_CD min_NN )_) ._SENT The_DT PCR_NP products_NNS were_VBD gel_NN purified_VBN (_( Qiagen_NP ,_, Valencia_NP ,_, Calif._NP )_) and_CC either_RB cloned_VBN into_IN the_DT PCR2.1_JJ plasmid_NN vector_NN (_( Invitrogen_NP )_) or_CC directly_RB sequenced_JJ ._SENT The_DT subcloned_JJ EMCV_NP 30/87_CD gene_NN segments_NNS were_VBD sequenced_VBN with_IN T7_JJ forward_JJ primers_NNS and_CC M13_JJ reverse_JJ primers_NNS ._SENT Three_CD independent_JJ clones_NNS of_IN each_DT segment_NN ,_, and_CC more_JJR than_IN five_CD clones_NNS for_IN the_DT poly_NN (_( C_NP )_) tract_NN ,_, were_VBD sequenced_JJ ._SENT For_IN the_DT 5_CD '_POS and_CC 3_CD '_'' ends_NNS of_IN EMCV_NP 30/87_CD ,_, the_DT GeneRace_NP kit_NN (_( Invitrogen_NP )_) was_VBD used_VBN as_IN described_VBN previously_RB ._SENT Nucleotide_NN sequence_NN analysis_NN ._SENT |_SYM Nucleotide_NN sequence_NN editing_VBG and_CC prediction_NN of_IN amino_NN acid_NN sequences_NNS were_VBD performed_VBN with_IN DNAStar_NP (_( Madison_NP ,_, Wis._NP )_) software_NN ._SENT Alignments_NNS were_VBD performed_VBN by_IN the_DT CLUSTALW_JJ method_NN by_IN using_VBG the_DT following_VBG previously_RB sequenced_JJ EMCV_NP strains_NNS :_: Mengo_NN virus_NN M/48_NP (_( GenBank_NP accession_NN number_NN )_) ,_, EMCV_NP R/45_NP (_( accession_NN number_NN )_) ,_, EMC-B/58_NP (_( accession_NN number_NN )_) ,_, EMC-D/58_NP (_( accession_NN number_NN )_) ,_, PV2/58_NP (_( accession_NN number_NN )_) ,_, PV21/58_NP (_( accession_NN number_NN )_) ,_, and_CC 2887A/91_JJ (_( accession_NN number_NN )_) ._SENT Nucleotide_NN and_CC predicted_VBD amino_NN acid_NN sequences_NNS were_VBD compared_VBN for_IN each_DT of_IN the_DT 12_CD genes_NNS and_CC proteins_NNS (_( leader_NN ,_, VP1_NP ,_, VP2_NP ,_, VP3_NP ,_, VP4_NP ,_, 2A_NP ,_, 2B_JJ ,_, 2C_JJ ,_, 3A_JJ ,_, 3B_JJ ,_, 3C_JJ ,_, and_CC 3D_JJ )_) and_CC also_RB for_IN the_DT long_JJ 5_CD '_'' and_CC short_JJ 3_CD '_POS NTRs_NN ._SENT To_TO determine_VB relationships_NNS among_IN the_DT EMCV_NP strains_NNS ,_, phylogenetic_JJ analysis_NN of_IN the_DT predicted_VBN amino_NN acid_NN sequences_NNS for_IN the_DT translated_VBN region_NN was_VBD performed_VBN with_IN PAUP_JJ (_( phylogenetic_JJ analysis_NN using_VBG parsimony_NN )_) software_NN utilizing_VBG both_DT parsimony_NN and_CC neighbor-joining_NN analyses_NNS ._SENT The_DT two_CD analyses_NNS resulted_VBN in_IN duplicate_JJ phylogenetic_JJ relationships_NNS and_CC were_VBD each_DT evaluated_VBN with_IN 2,000_CD bootstrap_NN replicates_VBZ ._SENT Infection_NN of_IN mice_NNS ._SENT |_SYM Four-_NP to_TO 6-week-old_JJ C57BL/6_NP mice_NNS were_VBD purchased_VBN from_IN Jackson_NP Laboratory_NP and_CC housed_VBN in_IN the_DT University_NP of_IN Minnesota_NP biosafety_NN level-2_NN mouse_NN facilities_NNS at_IN the_DT St._NP Paul_NP campus_NN ._SENT Handling_VBG of_IN animals_NNS ,_, including_VBG feeding_NN and_CC euthanasia_NN ,_, was_VBD in_IN conformity_NN with_IN the_DT National_NP Institutes_NPS of_IN Health_NP and_CC University_NP of_IN Minnesota_NP institutional_JJ animal_NN care_NN guidelines_NNS ._SENT Mice_NNS were_VBD intraperitoneally_RB inoculated_VBN with_IN 104_CD ,_, 100_CD ,_, or_CC 2_CD PFU_NP of_IN EMCV_NP 30/87_CD in_IN a_DT 1-ml_JJ volume_NN and_CC were_VBD monitored_VBN for_IN clinical_JJ signs_NNS of_IN EMCV_NP disease_NN ._SENT Terminally_RB sick_JJ mice_NNS were_VBD euthanatized_JJ ,_, whereas_IN mice_NNS that_WDT did_VBD not_RB develop_VB clinical_JJ disease_NN (_( mice_NNS inoculated_VBN with_IN 2_CD PFU_NP )_) were_VBD sacrificed_VBN at_IN day_NN 14_CD ,_, 21_CD ,_, or_CC 45_CD postinfection_NN (_( p.i._JJ )_) ._SENT Infection_NN of_IN pigs_NNS ._SENT |_SYM Thirty-seven_NP 5-week-old_JJ pigs_NNS were_VBD obtained_VBN from_IN an_DT EMCV-free_JJ swine_NN herd_NN (_( Midwest_NP Research_NP Swine_NP ,_, Gibbon_NP ,_, Minn._NP )_) and_CC placed_VBN in_IN negative-pressure_JJ isolation_NN units_NNS at_IN the_DT University_NP of_IN Minnesota_NP animal_NN facilities_NNS ._SENT An_DT enzyme-linked_JJ immunosorbent_JJ assay_NN (_( ELISA_NP )_) was_VBD used_VBN to_TO confirm_VB that_IN the_DT pigs_NNS were_VBD negative_JJ for_IN EMCV_NP antibodies_NNS before_IN infection_NN ._SENT Animals_NNS were_VBD intraperitoneally_RB inoculated_VBN with_IN 2.9_CD x_SYM 108_CD PFU_NP of_IN EMCV_NP 30/87_CD in_IN a_DT 1-ml_JJ volume_NN ._SENT Handling_VBG of_IN animals_NNS ,_, including_VBG feeding_NN and_CC euthanasia_NN ,_, was_VBD in_IN conformity_NN with_IN National_NP Institutes_NPS of_IN Health_NP and_CC University_NP of_IN Minnesota_NP institutional_JJ animal_NN care_NN guidelines_NNS ._SENT Four_CD to_TO six_CD pigs_NNS were_VBD euthanized_JJ on_IN days_NNS 7_CD ,_, 21_CD ,_, 45_CD ,_, and_CC 90_CD p.i._NN by_IN using_VBG pentobarbital_JJ sodium_NN ._SENT Tissues_NNS from_IN the_DT brain_NN ,_, heart_NN ,_, kidney_NN ,_, liver_NN ,_, spleen_NN ,_, skeletal_JJ muscle_NN ,_, and_CC pancreas_NN were_VBD collected_VBN for_IN isolation_NN of_IN infectious_JJ virus_NN and_CC viral_JJ RNA_NP ,_, histopathology_NN ,_, and_CC immunohistochemistry_NN ._SENT Infection_NN of_IN cynomolgus_NN macaques_NNS ._SENT |_SYM Fourteen_NP 2-_CD to_TO 4-year-old_JJ specific-pathogen-free_JJ cynomolgus_NN macaques_NNS (_( Macaca_NP fascicularis_NP )_) were_VBD purchased_VBN from_IN Charles_NP River_NP BRF_NP (_( Houston_NP ,_, Tex._NP )_) and_CC housed_VBN at_IN Gwathmey_NP Incorporated_NP (_( Cambridge_NP ,_, Mass._NP )_) animal_NN facilities_NNS ,_, where_WRB experiments_NNS were_VBD performed_VBN ._SENT Protocols_NNS for_IN handling_VBG of_IN the_DT macaques_NNS ,_, including_VBG feeding_NN and_CC euthanasia_NN ,_, were_VBD approved_VBN by_IN both_DT Gwathmey_NP Inc._NP and_CC the_DT University_NP of_IN Minnesota_NP Institutional_NP Animal_NP Care_NP and_CC Use_NP Committee_NP and_CC were_VBD in_IN conformity_NN with_IN the_DT National_NP Institutes_NPS of_IN Health_NP guidelines_NNS ._SENT Twelve_NP macaques_NNS were_VBD intraperitoneally_RB inoculated_VBN with_IN 2.9_CD x_SYM 108_CD PFU_NP of_IN EMCV_NP 30/87_CD in_IN a_DT 1-ml_JJ volume_NN ,_, and_CC two_CD macaques_NNS were_VBD inoculated_VBN with_IN sterile_JJ buffer_NN as_IN controls_NNS ._SENT Macaques_NNS were_VBD monitored_VBN daily_RB for_IN clinical_JJ signs_NNS of_IN EMCV_NP disease_NN ,_, and_CC three_CD animals_NNS were_VBD sacrificed_VBN at_IN days_NNS 14_CD ,_, 21_CD ,_, and_CC 45_CD p.i._NN for_IN collection_NN of_IN the_DT brain_NN ,_, heart_NN ,_, kidney_NN ,_, liver_NN ,_, spleen_NN ,_, skeletal_JJ muscle_NN ,_, and_CC pancreas_NN ._SENT Tissues_NNS were_VBD analyzed_VBN for_IN histopathologic_JJ and_CC immunohistochemical_JJ changes_NNS and_CC for_IN the_DT presence_NN of_IN infectious_JJ virus_NN and_CC viral_JJ RNA_NP ._SENT Sample_NN processing_NN and_CC histopathologic_JJ analysis_NN ._SENT |_SYM Sections_NNS of_IN heart_NN ,_, brain_NN ,_, liver_NN ,_, kidney_NN ,_, spleen_NN ,_, skeletal_JJ muscle_NN ,_, and_CC pancreas_NN from_IN pigs_NNS ,_, macaques_NNS ,_, and_CC mice_NNS infected_VBN with_IN EMCV_NP for_IN 2_CD ,_, 7_CD ,_, 14_CD ,_, 21_CD ,_, or_CC 45_CD to_TO 50_CD days_NNS were_VBD collected_VBN for_IN histopathologic_JJ analysis_NN ,_, virus_NN isolation_NN ,_, and_CC RNA_NP isolation_NN ._SENT Tissues_NNS for_IN RNA_NP isolation_NN were_VBD snap-frozen_VBN in_IN liquid_JJ nitrogen_NN ,_, whereas_IN tissues_NNS for_IN histopathology_NN and_CC in_IN situ_NN hybridization_NN were_VBD fixed_VBN in_IN 10_CD %_NN neutral_JJ buffered_VBN formalin_NN and_CC embedded_VBN in_IN paraffin_NN ._SENT Paraffin-embedded_JJ sections_NNS were_VBD cut_VBN at_IN a_DT thickness_NN of_IN 4_CD mum_JJ and_CC stained_VBN with_IN hematoxylin_NN and_CC eosin_NN for_IN histopathologic_JJ analysis_NN ._SENT Serum_NN samples_NNS collected_VBN from_IN the_DT animals_NNS at_IN sacrifice_NN were_VBD used_VBN to_TO determine_VB levels_NNS of_IN virus-specific_JJ immunoglobulin_NN G_NP (_( IgG_NP )_) by_IN ELISA_NP ._SENT In_IN situ_NN hybridization_NN ._SENT |_SYM To_TO detect_VB the_DT presence_NN of_IN viral_JJ genomes_NNS in_IN pig_NN tissues_NNS ,_, in_IN situ_NN hybridization_NN was_VBD performed_VBN by_IN using_VBG a_DT 414-bp_JJ VP1-specific_JJ probe_NN as_RB described_VBD previously_RB for_IN Theiler_NP 's_POS murine_JJ encephalomyelitis_NN virus_NN ._SENT Briefly_RB ,_, a_DT VP1_NP cDNA_NN was_VBD subcloned_VBN from_IN EMCV_NP 30/87_CD into_IN plasmid_NN pUC18_NN by_IN using_VBG BamHI_NP and_CC HindIII_NP restriction_NN sites_NNS ,_, and_CC the_DT cDNA_NN probe_NN was_VBD prepared_VBN by_IN digesting_VBG the_DT VP1_JJ plasmid_NN with_IN the_DT NcoI_NP and_CC BamHI_NP restriction_NN enzymes_NNS ._SENT The_DT probe_NN was_VBD labeled_VBN with_IN 35S-dATP_JJ by_IN using_VBG the_DT Random_NP Primers_NP DNA_NP labeling_VBG system_NN (_( Invitrogen_NP )_) and_CC was_VBD purified_VBN by_IN using_VBG G-50_NP Sephadex_NP Quick_NP Spin_NP columns_NNS (_( Roche_NP ,_, Indianapolis_NP ,_, Ind._NP )_) ._SENT To_TO prepare_VB tissue_NN samples_NNS ,_, paraffin-embedded_NN sections_NNS were_VBD deparaffinized_VBN by_IN using_VBG xylene_NN ._SENT Sections_NNS were_VBD first_RB digested_VBN with_IN 10_CD mug_NN of_IN proteinase_NN K/ml_NN in_IN phosphate-buffered_JJ saline_NN for_IN 30_CD min_NN at_IN 37C_JJ and_CC then_RB treated_VBN with_IN 0.1_CD M_NN triethanolamine_NN containing_VBG acetic_JJ anhydride_NN ._SENT The_DT sections_NNS were_VBD prehybridized_JJ in_IN a_DT buffer_NN containing_VBG deionized_JJ formamide_NN ,_, Denhardt_NP 's_POS solution_NN ,_, sodium_NN chloride_NN ,_, salmon_NN sperm_NN DNA_NN ,_, yeast_NN total_NN RNA_NP ,_, and_CC yeast_NN tRNA_NN for_IN 4_CD h_NN at_IN room_NN temperature_NN before_IN hybridization_NN with_IN a_DT 35S-labeled_JJ 309-bp_JJ VP1_JJ probe_NN ._SENT Hybridization_NN was_VBD performed_VBN overnight_RB at_IN 37C_NP and_CC was_VBD followed_VBN by_IN extensive_JJ washes_VBZ in_IN reducing_VBG buffer_NN at_IN 55C_NP ._SENT Air-dried_VBN slides_NNS were_VBD immersed_VBN in_IN an_DT NTB2_JJ film_NN emulsion_NN (_( Eastman_NP Kodak_NP Co._NP ,_, Rochester_NP ,_, N.Y._NP )_) and_CC exposed_VBN at_IN 4C_JJ for_IN 5_CD days_NNS ._SENT RT-PCR_NP ._SENT |_SYM Pig_NP ,_, macaque_NN ,_, and_CC mouse_NN tissues_NNS collected_VBN at_IN days_NNS 2_CD ,_, 7_CD ,_, 14_CD ,_, 21_CD ,_, 45_CD ,_, and_CC 90_CD p.i._NN were_VBD analyzed_VBN for_IN EMCV_NP RNA_NP by_IN nested_VBN reverse_JJ transcription-PCR_NN (_( RT-PCR_NP )_) as_RB described_VBD previously_RB ._SENT Samples_NNS of_IN brain_NN ,_, heart_NN ,_, liver_NN ,_, kidney_NN ,_, spleen_NN ,_, or_CC skeletal_JJ muscle_NN tissues_NNS were_VBD homogenized_VBN in_IN TRIzol_NP (_( Invitrogen_NP )_) ,_, followed_VBN by_IN chloroform_NN extraction_NN of_IN total_JJ RNA_NP ._SENT Five_CD micrograms_NNS of_IN total_JJ RNA_NP was_VBD reverse_RB transcribed_VBN by_IN using_VBG an_DT oligo(dT)_JJ primer_NN and_CC the_DT Superscript_JJ II_NP reverse_NN transcription_NN kit_NN (_( Invitrogen_NP )_) before_IN the_DT outer_JJ and_CC nesting_VBG PCRs_NNS were_VBD performed_VBN using_VBG primer_JJR pairs_NNS specific_JJ for_IN the_DT VP1_NP or_CC VP2_NP gene_NN of_IN EMCV_NP 30/87_CD sequenced_NN in_IN our_PP$ laboratory_NN ._SENT The_DT VP1_JJ primers_NNS used_VBN for_IN the_DT outer_JJ PCR_NP were_VBD GCCTCAGTTTGACCCTGCTTATG_NP (_( 5_CD '_POS primer_NN )_) and_CC CGGCTCTCGGAGTCATGTCAATC_NP (_( 3_CD '_POS primer_NN )_) (_( product_NN size_NN ,_, 592_CD bp_NN )_) ,_, and_CC those_DT for_IN the_DT nesting_VBG reaction_NN were_VBD CGTCTCACAGAAATTTGGGGCAAC_NP (_( 5_CD '_POS primer_NN )_) and_CC CCAGGCTTCCTGTGTTGTCAAATC_NP (_( 3_CD '_POS primer_NN )_) (_( product_NN size_NN ,_, 340_CD bp_NN )_) ._SENT The_DT VP2_NP primers_NNS for_IN the_DT outer_JJ PCR_NP were_VBD CAGTAGGCCGTCTTGTTGGTTATG_NP for_IN the_DT 5_CD '_POS end_NN and_CC CACTTCAAGATCCACGGTGGTGTTG_NN for_IN the_DT 3_CD '_POS end_NN (_( product_NN size_NN ,_, 499_CD bp_NN )_) ,_, and_CC the_DT nesting_VBG primers_NNS were_VBD GGCACTGTTCATGATGGAGAACAC_NP for_IN the_DT 5_CD '_POS end_NN and_CC GGTGATCCATAGCAAAGGGACCTTTC_NP for_IN the_DT 3_CD '_POS end_NN (_( product_NN size_NN ,_, 350_CD bp_NN )_) ._SENT All_DT primer_NN sequences_NNS are_VBP given_VBN in_IN 5'-to-3_NP '_POS orientation_NN ._SENT The_DT outer_JJ PCR_NP was_VBD performed_VBN on_IN 1_CD mul_NN of_IN the_DT template_NN cDNA_NN by_IN adding_VBG 0.2_CD mM_NP deoxynucleoside_NN triphosphates_NNS ,_, 2_CD mM_NP magnesium_NN chloride_NN ,_, 10_CD pmol_NN of_IN each_DT primer_NN ,_, and_CC 1_CD U_NN of_IN Taq_NP polymerase_NN (_( Invitrogen_NP )_) ._SENT For_IN the_DT nested_VBN PCR_NP ,_, 2.5_CD mul_NN of_IN the_DT first-round_NP PCR_NP mixture_NN was_VBD used_VBN ._SENT PCR_NP products_NNS were_VBD analyzed_VBN by_IN agarose_JJ gel_NN electrophoresis_NN ._SENT Nucleotide_NN sequence_NN accession_NN number_NN ._SENT |_SYM Nucleotide_NN sequences_NNS for_IN EMCV_NP 30/87_CD have_VBP been_VBN submitted_VBN to_TO GenBank_NP (_( accession_NN number_NN )_) ._SENT Molecular_JJ analysis_NN of_IN EMCV_NP 30/87_CD and_CC comparison_NN with_IN other_JJ EMCV_NP strains_NNS ._SENT |_SYM The_DT entire_JJ EMCV_NP 30/87_CD genome_NN was_VBD sequenced_VBN for_IN comparison_NN with_IN other_JJ EMCV_NP strains_NNS and_CC correlated_VBN with_IN the_DT pathogenesis_NN of_IN virus_NN infection_NN in_IN different_JJ animal_NN species_NNS ._SENT The_DT sizes_NNS of_IN the_DT LP_NP ,_, VP1_NP ,_, VP2_NP ,_, VP3_NP ,_, VP4_NP ,_, 2A_NP ,_, 2B_JJ ,_, 2C_JJ ,_, 3A_JJ ,_, 3B_JJ ,_, 3C_JJ ,_, and_CC 3D_JJ genes_NNS of_IN EMCV_NP 30/87_CD (_( GenBank_NP accession_NN number_NN )_) were_VBD similar_JJ to_TO those_DT of_IN strains_NNS 2887A/91_JJ (_( accession_NN number_NN )_) ,_, EMCV_NP R/45_NP (_( accession_NN number_NN )_) ,_, PV21/58_NP (_( accession_NN number_NN )_) ,_, EMC-B/58_NP (_( accession_NN number_NN )_) ,_, EMC-D/58_NP (_( accession_NN number_NN )_) ,_, and_CC PV2/58_NP (_( accession_NN number_NN )_) ._SENT However_RB ,_, Mengo_NP virus_NN M/48_NP (_( accession_NN number_NN )_) had_VBD an_DT extra_JJ amino_NN acid_NN (_( proline_NN )_) in_IN the_DT 2B_JJ protein_NN at_IN position_NN 10_CD from_IN the_DT N_NP terminus_NN of_IN the_DT protein_NN ._SENT Comparison_NN of_IN the_DT nucleotide_NN and_CC predicted_VBD amino_NN acid_NN sequences_NNS for_IN the_DT coding_VBG regions_NNS encompassing_VBG the_DT 12_CD genes_NNS demonstrated_VBD that_IN EMCV_NP 30/87_CD shared_VBD the_DT highest_JJS overall_JJ nucleotide_NN sequence_NN identity_NN (_( 84.2_CD %_NN )_) and_CC predicted_VBD amino_NN acid_NN identity_NN (_( 96.4_CD %_NN )_) with_IN strain_NN 2887A/91_JJ ,_, isolated_VBN from_IN an_DT aborted_JJ porcine_JJ fetus_NN in_IN Belgium_NP ,_, and_CC with_IN strain_NN PV21/58_NP ,_, a_DT laboratory_NN isolate_NN from_IN a_DT virus_NN isolated_VBN from_IN a_DT pig_NN myocardium_NN in_IN Panama_NP (_( Tables_NP and_CC )_) ._SENT EMCV_NP 30/87_CD also_RB had_VBD high_JJ nucleotide_NN (_( 84.0_CD %_NN )_) and_CC amino_NN acid_NN (_( 96.6_CD %_NN )_) sequence_NN identities_NNS with_IN EMCV_NP R/45_NP ,_, isolated_VBN from_IN the_DT myocardium_NN of_IN a_DT chimpanzee_NN ._SENT Of_IN the_DT 12_CD EMCV_NP genes_NNS ,_, 2B_JJ was_VBD the_DT most_RBS conserved_VBN among_IN the_DT eight_CD EMCV_NP strains_NNS ,_, demonstrating_VBG 90.4_CD to_TO 94.2_CD %_NN nucleotide_NN sequence_NN identity_NN and_CC 94.7_CD to_TO 97.3_CD %_NN predicted_VBD amino_NN acid_NN identity_NN (_( Tables_NP and_CC )_) ._SENT Phylogenetic_JJ comparison_NN of_IN the_DT seven_CD EMCV_NP strains_NNS and_CC Mengo_NP virus_NN revealed_VBD the_DT closeness_NN of_IN EMC-B/58_NP ,_, EMC-D/58_NP ,_, and_CC PV2/58_NP ,_, all_DT of_IN which_WDT are_VBP variant_JJ mutants_NNS derived_VBN from_IN EMCV-M_NP ._SENT EMCV_NP R/45_NP and_CC 2887A/91_JJ segregated_JJ together_RB ,_, and_CC EMCV_NP 30/87_CD appeared_VBD to_TO segregate_VB between_IN the_DT two_CD clusters_NNS ._SENT Mengo_NP virus_NN M/48_NP segregated_VBD far_RB from_IN the_DT seven_CD EMCV_NP strains_NNS ._SENT Perhaps_RB the_DT most_RBS intriguing_JJ finding_NN was_VBD that_IN EMCV_NP 30/87_CD had_VBD the_DT shortest_JJS poly(C)_NN tract_NN ,_, which_WDT was_VBD observed_VBN both_CC in_IN a_DT mixed_JJ population_NN of_IN low-passage-number_JJ EMCV_NP 30_CD used_VBD to_TO inoculate_VB mice_NNS and_CC in_IN two_CD plaque-purified_JJ strains_NNS of_IN the_DT virus_NN (_( EMCV_NP 30/PA_NP and_CC EMCV_NP 30/PB_NP )_) ._SENT EMCV_NP 30/87_CD had_VBD a_DT poly(C)_JJ tract_NN consisting_VBG of_IN 14_CD C_NP 's_POS (_( CUC5UC8_NP )_) ,_, whereas_IN the_DT older_JJR EMCV_NP isolates_NNS (_( EMCV_NP R/45_NP ,_, PV2/58_NP ,_, PV21/58_NP ,_, EMC-B/58_NP ,_, and_CC EMC-D/58_NP )_) had_VBD 118_CD to_TO 142_CD C_NP 's_POS and_CC Mengo_NP virus_NN M/48_NP had_VBD 61_CD C_NP 's_POS ._SENT Strain_NN 2887A/91_JJ ,_, another_DT recent_JJ isolate_NN from_IN an_DT aborted_JJ pig_NN fetus_NN ,_, also_RB had_VBD a_DT short_JJ poly(C)_NN tract_NN (_( C10UCUC3UC10_NP )_) and_CC was_VBD highly_RB pathogenic_JJ ._SENT The_DT 5_CD '_POS NTR_NP of_IN EMCV_NP 30/87_CD consisted_VBD of_IN approximately_RB 724_CD nucleotides_NNS ,_, a_DT size_NN comparable_JJ to_TO that_DT of_IN strain_NN 2887A/91_JJ (_( 728_CD nucleotides_NNS )_) but_CC 135_CD nucleotides_NNS shorter_JJR than_IN that_DT of_IN PV21/58_NP ,_, the_DT virus_NN with_IN the_DT longest_JJS poly(C)_NN tract_NN ._SENT The_DT 10_CD to_TO 21_CD nucleotides_NNS at_IN the_DT immediate_JJ 5_CD '_POS side_NN of_IN the_DT poly(C)_JJ tract_NN consisted_VBN of_IN 60_CD to_TO 75_CD %_NN A_DT residues_NNS ,_, leading_VBG to_TO a_DT highly_RB conserved_VBN region_NN in_IN all_DT EMCV_NP strains_NNS and_CC Mengo_NP virus_NN ._SENT Another_DT conserved_VBN region_NN was_VBD observed_VBN 4_CD to_TO 6_CD nucleotides_NNS downstream_JJ of_IN the_DT poly(C)_JJ tract_NN ._SENT Analysis_NN of_IN the_DT 3_CD '_POS NTR_NP of_IN EMCV_NP 30/87_CD revealed_VBD no_DT major_JJ differences_NNS among_IN eight_CD EMCV_NP strains_NNS ._SENT The_DT 3_CD '_POS NTR_NP consisted_VBD of_IN 125_CD nucleotides_NNS in_IN addition_NN to_TO a_DT short_JJ poly(A)_NN tail_NN ,_, which_WDT was_VBD comparable_JJ to_TO the_DT 3_CD '_POS NTRs_NN of_IN all_DT other_JJ EMCV_NP strains_NNS (_( 107_CD to_TO 126_CD nucleotides_NNS )_) and_CC Mengo_NP virus_NN M/48_NP (_( 125_CD nucleotides_NNS )_) ._SENT EMCV-induced_JJ clinical_JJ disease_NN in_IN mice_NNS ,_, pigs_NNS ,_, and_CC macaques_NNS ._SENT |_SYM All_NP mice_NNS (_( n_NN =_SYM 25_LS )_) inoculated_VBN with_IN >=4_NP PFU_NP of_IN EMCV_NP 30/87_CD died_VBD between_IN days_NNS 2_CD and_CC 7_CD p.i._NN from_IN acute_JJ encephalitis_NN ._SENT The_DT clinical_JJ signs_NNS in_IN mice_NNS included_VBD hunched_VBN posture_NN ,_, ruffled_VBN fur_NN ,_, lethargy_NN ,_, anorexia_NN ,_, and_CC hind_JJ limb_NN paralysis_NN ._SENT The_DT clinical_JJ signs_NNS lasted_VBN for_IN 24_CD to_TO 72_CD h_NN before_IN mice_NNS became_VBD moribund_JJ with_IN signs_NNS of_IN severe_JJ respiratory_JJ failure_NN ._SENT No_DT mice_NNS died_VBN of_IN sudden_JJ cardiac_JJ failure_NN ,_, which_WDT was_VBD observed_VBN in_IN 16_CD %_NN of_IN EMCV_NP 30/87-infected_JJ pigs_NNS ._SENT Mice_NNS inoculated_VBN with_IN 104_CD to_TO 105_CD PFU_NN of_IN EMCV_NP 30/87_CD developed_VBD disease_NN 2_CD to_TO 4_CD days_NNS p.i._JJ ,_, whereas_IN mice_NNS inoculated_VBN with_IN 4_CD to_TO 100_CD PFU_NN of_IN virus_NN developed_VBN disease_NN between_IN days_NNS 5_CD and_CC 7_CD p.i._NP Terminally_NP ,_, mice_NNS developed_VBD posterior_JJ limb_NN paresis_NN or_CC complete_JJ paralysis_NN before_IN rapidly_RB becoming_VBG moribund_JJ ._SENT Six_CD of_IN the_DT 37_CD pigs_NNS inoculated_VBN with_IN 2.9_CD x_SYM 108_CD PFU_NP of_IN EMCV_NP 30/87_CD (_( 16.2_CD %_NN )_) died_VBD of_IN acute_JJ myocardial_JJ failure_NN 2_CD to_TO 3_CD days_NNS later_RBR ._SENT The_DT rest_NN of_IN the_DT pigs_NNS did_VBD not_RB develop_VB any_DT overt_JJ clinical_JJ signs_NNS ._SENT None_NN of_IN the_DT 12_CD cynomolgus_NN macaques_NNS inoculated_VBN with_IN 2.9_CD x_SYM 108_CD PFU_NP of_IN EMCV_NP 30/87_CD (_( the_DT same_JJ virus_NN dose_NN as_IN that_DT given_VBN to_TO pigs_NNS )_) developed_VBD detectable_JJ clinical_JJ signs_NNS ._SENT Electrocardiographic_JJ profiles_NNS were_VBD not_RB determined_VBN for_IN mice_NNS ,_, pigs_NNS ,_, or_CC macaques_NNS ._SENT A_DT summary_NN of_IN the_DT survival_NN curves_VBZ of_IN mice_NNS ,_, pigs_NNS ,_, and_CC macaques_NNS following_VBG EMCV_NP infection_NN is_VBZ presented_VBN in_IN Fig._NN ._SENT Sham-inoculated_JJ pigs_NNS (_( n_NN =_SYM 2_CD )_) ,_, mice_NNS (_( n_NN =_SYM 4_CD )_) ,_, and_CC macaques_NNS (_( n_NN =_SYM 2_LS )_) remained_VBN asymptomatic_JJ throughout_IN the_DT experimental_JJ period_NN and_CC had_VBD no_DT fatalities_NNS ._SENT Pathogenesis_NN of_IN EMCV_NP 30/87_CD in_IN mice_NNS ._SENT |_SYM All_NP EMCV_NP 30/87-infected_JJ mice_NNS died_VBN within_IN 2_CD to_TO 7_CD days_NNS ._SENT Following_VBG intraperitoneal_JJ inoculation_NN ,_, there_EX was_VBD widespread_JJ virus_NN distribution_NN ,_, as_RB demonstrated_VBN by_IN detection_NN of_IN EMCV_NP RNA_NP in_IN the_DT blood_NN ,_, spleen_NN ,_, kidneys_NNS ,_, liver_NN ,_, heart_NN ,_, brain_NN ,_, and_CC skeletal_JJ muscle_NN by_IN RT-PCR_NP (_( Fig._NN ;_: Table_NP )_) ._SENT Viral_JJ RNA_NP could_MD also_RB be_VB localized_VBN by_IN in_IN situ_NN hybridization_NN ,_, particularly_RB in_IN tissue_NN sections_NNS from_IN the_DT heart_NN and_CC brain_NN ._SENT Histopathologic_JJ changes_NNS were_VBD observed_VBN in_IN the_DT heart_NN and_CC brain_NN but_CC not_RB in_IN the_DT liver_NN ,_, spleen_NN ,_, kidney_NN ,_, pancreas_NN ,_, or_CC skeletal_JJ muscle_NN ._SENT In_IN the_DT heart_NN ,_, there_EX were_VBD large_JJ foci_NNS of_IN lymphocytic_JJ infiltration_NN in_IN the_DT myocardium_NN ,_, accompanied_VBN by_IN degeneration_NN and_CC necrosis_NN of_IN cardiac_JJ myocytes_NNS and_CC sarcoplasm_NN ._SENT In_IN the_DT brain_NN ,_, similar_JJ foci_NNS of_IN lymphocytic_JJ infiltration_NN were_VBD observed_VBN in_IN the_DT cerebral_JJ cortices_NNS ,_, hypothalami_NNS ,_, and_CC hippocampi_NNS ._SENT To_TO investigate_VB whether_IN EMCV_NP persistence_NN and_CC chronic_JJ disease_NN can_MD occur_VB in_IN mice_NNS ,_, we_PP inoculated_VBD mice_NNS (_( n_NN =_SYM 8_CD )_) with_IN lower_JJR titers_NNS (_( 2_CD to_TO 10_CD PFU_NN )_) ,_, but_CC they_PP did_VBD not_RB develop_VB either_DT clinical_JJ disease_NN or_CC anti-EMCV_NN antibodies_NNS ,_, indicating_VBG that_IN the_DT virus_NN titers_NNS were_VBD too_RB low_JJ to_TO establish_VB an_DT infection_NN ._SENT In_IN addition_NN ,_, no_DT EMCV_NP RNA_NP was_VBD detected_VBN in_IN the_DT brain_NN ,_, heart_NN ,_, spleen_NN ,_, pancreas_NN ,_, blood_NN ,_, kidney_NN ,_, liver_NN ,_, or_CC skeletal_JJ muscle_NN in_IN these_DT mice_NNS 21_CD days_NNS p.i._JJ ,_, further_RBR indicating_VBG that_IN no_DT infection_NN was_VBD established_VBN ._SENT Pathogenesis_NN of_IN EMCV_NP 30/87_CD in_IN pigs_NNS ._SENT |_SYM The_DT detailed_JJ clinical_JJ and_CC histopathologic_JJ profile_NN of_IN EMCV_NP 30/87_CD in_IN swine_NN has_VBZ been_VBN described_VBN previously_RB ._SENT Limited_JJ experiments_NNS performed_VBN to_TO provide_VB data_NNS for_IN direct_JJ comparison_NN with_IN viral_JJ pathogenesis_NN in_IN mice_NNS and_CC cynomolgus_NN macaques_NNS reaffirmed_VBD that_IN the_DT virus_NN replicated_VBN primarily_RB in_IN the_DT brain_NN ,_, heart_NN ,_, and_CC spleen_NN ,_, rarely_RB in_IN the_DT liver_NN ,_, and_CC not_RB in_IN the_DT kidneys_NNS and_CC skeletal_JJ muscles_NNS during_IN the_DT first_JJ 7_CD days_NNS ._SENT However_RB ,_, in_IN the_DT chronic_JJ phase_NN of_IN the_DT disease_NN ,_, persistent_JJ viral_JJ RNA_NP was_VBD more_RBR widespread_JJ and_CC was_VBD detected_VBN in_IN the_DT brain_NN ,_, liver_NN ,_, heart_NN ,_, spleen_NN ,_, kidney_NN ,_, pancreas_NN ,_, and_CC skeletal_JJ muscles_NNS ._SENT Histopathologic_JJ changes_NNS in_IN both_CC the_DT acute_JJ and_CC chronic_JJ phases_NNS were_VBD confined_VBN to_TO the_DT heart_NN and_CC brain_NN ._SENT Pigs_NNS sacrificed_VBN in_IN the_DT acute_JJ phase_NN of_IN the_DT disease_NN (_( days_NNS 7_CD to_TO 21_CD p.i._NN )_) exhibited_VBD severe_JJ myocardial_JJ lesions_NNS ,_, including_VBG multiple_JJ foci_NNS of_IN lymphocytic_JJ infiltration_NN ,_, degeneration_NN ,_, and_CC necrosis_NN ._SENT Brain_NN changes_NNS included_VBD infiltration_NN of_IN lymphocytes_NNS in_IN the_DT cerebral_JJ cortices_NNS and_CC meninges_NNS ,_, as_RB well_RB as_IN perivascular_JJ cuffing_VBG in_IN the_DT cerebral_JJ cortex_NN and_CC hippocampi_NN ._SENT In_IN the_DT chronic_JJ phase_NN of_IN the_DT disease_NN (_( days_NNS 45_CD to_TO 90_CD p.i._NN )_) ,_, multiple_JJ discrete_JJ foci_NNS of_IN myocardial_JJ mineralization_NN and_CC lymphocytic_JJ infiltration_NN were_VBD observed_VBN ,_, which_WDT were_VBD larger_JJR and_CC more_RBR numerous_JJ than_IN the_DT lesions_NNS observed_VBN in_IN macaques_NNS ._SENT Brain_NN lesions_NNS in_IN the_DT chronic_JJ stages_NNS of_IN disease_NN were_VBD characterized_VBN by_IN perivascular_JJ cuffing_VBG in_IN the_DT cerebral_JJ cortex_NN ,_, medulla_NN ,_, and_CC cerebellum_NN ._SENT EMCV_NP persistence_NN in_IN the_DT heart_NN ,_, brain_NN ,_, liver_NN ,_, kidney_NN ,_, spleen_NN ,_, skeletal_JJ muscle_NN ,_, pancreas_NN ,_, and_CC mesenteric_JJ lymph_NN nodes_NNS during_IN the_DT acute_JJ phase_NN ,_, but_CC primarily_RB in_IN the_DT heart_NN and_CC brain_NN in_IN the_DT chronic_JJ phase_NN ,_, was_VBD demonstrated_VBN by_IN using_VBG in_IN situ_NN hybridization_NN and_CC RT-PCR_NP ._SENT There_EX was_VBD mild_JJ lymphocytic_JJ infiltration_NN in_IN the_DT spleen_NN in_IN the_DT acute_JJ phase_NN ,_, but_CC no_DT pathological_JJ changes_NNS were_VBD detected_VBN in_IN the_DT liver_NN ,_, pancreas_NN ,_, kidney_NN ,_, skeletal_JJ muscles_NNS ,_, or_CC mesenteric_JJ lymph_NN nodes_NNS at_IN any_DT stage_NN of_IN the_DT disease_NN ._SENT EMCV_NP pathogenesis_NN in_IN cynomolgus_NN macaques_NNS ._SENT |_SYM As_RB shown_VBN in_IN Fig._NN ,_, none_NN of_IN the_DT 12_CD infected_JJ macaques_NNS developed_VBD overt_JJ clinical_JJ signs_NNS ,_, and_CC there_EX were_VBD no_DT fatalities_NNS among_IN them_PP ,_, even_RB though_IN the_DT same_JJ dose_NN of_IN virus_NN (_( 2.9_CD x_SYM 108_CD PFU_NP )_) was_VBD used_VBN to_TO infect_VB both_DT pigs_NNS and_CC macaques_NNS ._SENT Following_VBG EMCV_NP 30/87_CD inoculation_NN ,_, viral_JJ RNA_NP was_VBD detected_VBN in_IN the_DT blood_NN ,_, spleen_NN ,_, liver_NN ,_, heart_NN ,_, kidney_NN ,_, brain_NN ,_, and_CC skeletal_JJ muscles_NNS (_( Fig._NN ;_: Table_NP )_) ._SENT The_DT viral_JJ RNA_NP localized_VBD by_IN in_IN situ_NN hybridization_NN in_IN the_DT heart_NN and_CC brain_NN were_VBD associated_VBN with_IN several_JJ pathological_JJ changes_NNS ._SENT However_RB ,_, although_IN viral_JJ RNA_NP was_VBD detected_VBN in_IN the_DT kidney_NN ,_, liver_NN ,_, spleen_NN ,_, pancreas_NN ,_, or_CC skeletal_JJ muscles_NNS at_IN day_NN 7_CD p.i._NN ,_, no_DT histopathologic_JJ abnormalities_NNS were_VBD demonstrated_VBN in_IN these_DT organs_NNS ,_, as_RB illustrated_VBN by_IN the_DT micrograph_NN showing_VBG viral_JJ RNA_NP in_IN the_DT kidney_NN despite_IN the_DT normal_JJ histology_NN of_IN the_DT organ_NN ._SENT Histopathologic_JJ changes_NNS in_IN the_DT brain_NN and_CC heart_NN were_VBD observed_VBN in_IN three_CD of_IN the_DT four_CD macaques_NNS at_IN day_NN 7_CD p.i._NN In_IN the_DT myocardium_NN ,_, there_EX were_VBD numerous_JJ large_JJ foci_NNS of_IN inflammation_NN associated_VBN with_IN necrosis_NN and_CC degeneration_NN of_IN cardiac_JJ myocytes_NNS ._SENT The_DT lesions_NNS were_VBD similar_JJ to_TO those_DT observed_VBN in_IN acutely_RB infected_JJ pigs_NNS but_CC were_VBD less_RBR frequent_JJ ,_, suggesting_VBG that_IN primate_NN myocytes_NNS were_VBD not_RB as_RB susceptible_JJ to_TO the_DT porcine_JJ virus_NN ._SENT Histopathologic_JJ changes_NNS in_IN the_DT brain_NN included_VBD numerous_JJ foci_NNS of_IN perivascular_JJ cuffing_VBG ,_, which_WDT were_VBD most_RBS prominent_JJ in_IN the_DT cerebrum_NN and_CC the_DT cerebral_JJ cortex_NN ._SENT There_EX were_VBD histopathologic_JJ changes_NNS in_IN 7_CD of_IN 8_CD spleens_NNS (_( 87.5_CD %_NN )_) ,_, 3_CD of_IN 8_CD hearts_NNS (_( 37.5_CD %_NN )_) ,_, and_CC 2_CD of_IN 8_CD brains_NNS (_( 25_CD %_NN )_) for_IN macaques_NNS infected_VBN for_IN 21_CD and_CC 45_CD days_NNS ._SENT Splenic_JJ lesions_NNS were_VBD characterized_VBN by_IN highly_RB prominent_JJ germinal_JJ centers_NNS in_IN the_DT chronically_RB infected_JJ macaques_NNS compared_VBN to_TO those_DT in_IN uninfected_JJ or_CC 7-day-infected_JJ macaques_NNS ._SENT Myocardial_JJ lesions_NNS were_VBD characterized_VBN by_IN small_JJ discrete_JJ foci_NNS of_IN lymphocytic_JJ infiltration_NN ,_, with_IN minimal_JJ disruption_NN of_IN cardiac_JJ myofiber_NN arrangement_NN ._SENT Brain_NN lesions_NNS included_VBD small_JJ foci_NNS of_IN infiltrating_VBG lymphocytes_NNS in_IN blood_NN vessel_NN walls_NNS ._SENT Analysis_NN of_IN viral_JJ RNA_NP distribution_NN by_IN in_IN situ_NN hybridization_NN and_CC RT-PCR_NP demonstrated_VBD EMCV_NP RNA_NP most_RBS consistently_RB in_IN the_DT spleen_NN (_( 75_CD %_NN of_IN the_DT cases_NNS at_IN day_NN 45_CD p.i._NN )_) ,_, but_CC also_RB in_IN the_DT heart_NN (_( 50_CD %_NN )_) ,_, brain_NN (_( 50_CD %_NN )_) ,_, pancreas_NN (_( 25_CD %_NN )_) ,_, and_CC kidney_NN (_( 25_CD %_NN )_) ,_, as_RB demonstrated_VBN in_IN Table_NP ._SENT Serum_NN samples_NNS from_IN macaques_NNS infected_VBN for_IN 7_CD days_NNS had_VBD low_JJ levels_NNS of_IN virus-specific_JJ IgG_NP ,_, whereas_IN high_JJ levels_NNS of_IN EMCV-specific_NP IgG_NP were_VBD detected_VBN at_IN both_DT days_NNS 21_CD and_CC 45_CD p.i._NN ._SENT Studies_NNS have_VBP suggested_VBN that_IN the_DT poly(C)_JJ tract_NN in_IN EMCV_NP strains_NNS and_CC Mengo_NP virus_NN may_MD be_VB a_DT determinant_NN in_IN pathogenesis_NN ,_, virulence_NN ,_, and_CC host_NN range_NN ._SENT Recombinant_JJ Mengo_NP virus_NN M/48_NN variants_NNS with_IN shortened_VBN poly(C)_JJ tracts_NNS (_( C0_NP or_CC C24_NP )_) were_VBD highly_RB attenuated_VBN ,_, producing_VBG either_RB no_DT histopathologic_JJ changes_NNS (_( C0_NP )_) or_CC mild_JJ meningitis_NN (_( C24_NP )_) in_IN 4-week-old_JJ mice_NNS ._SENT However_RB ,_, the_DT Mengo_NP virus_NN variants_NNS with_IN short_JJ poly(C)_NN tracts_NNS had_VBD growth_NN kinetics_NNS and_CC plaque_NN sizes_NNS similar_JJ to_TO those_DT of_IN wild-type_JJ Mengo_NP virus_NN M/48_NP (_( C63_NP )_) in_IN vitro_NN ,_, and_CC they_PP were_VBD immunogenic_JJ in_IN mice_NNS ,_, pigs_NNS ,_, and_CC macaques_NNS ,_, indicating_VBG that_IN the_DT viruses_NNS were_VBD infectious_JJ in_IN these_DT animals_NNS ._SENT After_IN sequencing_VBG the_DT genome_NN of_IN EMCV_NP 30/87_CD and_CC determining_VBG that_IN it_PP had_VBD the_DT shortest_JJS poly(C)_NN tract_NN (_( CUC5UC8_NP )_) of_IN all_DT wild-type_JJ EMCV_NP strains_NNS ,_, we_PP determined_VBD the_DT pathogenesis_NN and_CC virulence_NN of_IN the_DT virus_NN in_IN various_JJ animal_NN species_NNS ._SENT Our_PP$ data_NNS demonstrate_VBP that_IN EMCV_NP 30/87_CD ,_, a_DT low-passage-number_NN (_( 4_CD or_CC 5_CD passages_NNS )_) natural_JJ isolate_NN with_IN a_DT short_JJ poly(C)_NN tract_NN (_( CUC5UC8_NP )_) ,_, is_VBZ highly_RB virulent_JJ ,_, resulting_VBG in_IN substantial_JJ fatalities_NNS in_IN mice_NNS and_CC pigs_NNS and_CC severe_JJ pathological_JJ changes_NNS in_IN mice_NNS ,_, pigs_NNS ,_, and_CC macaques_NNS ._SENT Similar_JJ findings_NNS were_VBD observed_VBN with_IN the_DT wild-type_NN strain_VBP 2887A/91_JJ (_( C10UCUC3UC10_NP )_) ,_, which_WDT induced_VBD acute_JJ fatal_JJ encephalitis_NN characterized_VBN by_IN hind_JJ limb_NN paralysis_NN as_IN early_JJ as_IN day_NN 1_CD p.i._NN in_IN mice_NNS and_CC had_VBD a_DT 50_CD %_NN lethal_JJ dose_NN (_( LD50_NP )_) of_IN 1_CD PFU_NP ._SENT The_DT direct_JJ correlation_NN between_IN the_DT length_NN of_IN the_DT poly(C)_JJ tract_NN and_CC virulence_NN may_MD be_VB specific_JJ to_TO Mengo_NP virus_NN M/48_NP ,_, which_WDT is_VBZ phylogenetically_RB different_JJ from_IN most_JJS of_IN the_DT EMCVs_NP ,_, as_RB shown_VBN in_IN Fig._NN ._SENT This_DT hypothesis_NN is_VBZ supported_VBN by_IN studies_NNS using_VBG poly(C)_JJ tract_NN variants_NNS from_IN both_DT EMCV_NP R/45_NP and_CC PV2/58_NP ,_, which_WDT demonstrated_VBD no_DT correlation_NN between_IN the_DT length_NN of_IN the_DT poly(C)_JJ tract_NN and_CC virulence_NN ._SENT Another_DT possible_JJ explanation_NN for_IN the_DT correlation_NN between_IN virulence_NN and_CC the_DT length_NN of_IN the_DT poly(C)_JJ tract_NN in_IN Mengo_NP M_NP variants_NNS is_VBZ that_IN continuous_JJ passage_NN and_CC genetic_JJ engineering_NN of_IN EMCV_NP strains_NNS and_CC Mengo_NP virus_NN result_NN in_IN significant_JJ attenuation_NN ,_, as_RB demonstrated_VBN with_IN strain_NN 2887A/91_JJ ._SENT Comparison_NN of_IN the_DT parent_NN strain_NN 2887A/91_JJ and_CC an_DT infectious_JJ cDNA_NN clone_NN generated_VBN from_IN the_DT parent_NN virus_NN demonstrated_VBD that_IN the_DT recombinant_JJ 2887A/91_JJ clone_NN had_VBD smaller_JJR plaque_NN sizes_NNS ._SENT Mice_NNS inoculated_VBN with_IN the_DT infectious_JJ 2887A/91_JJ cDNA_NN clone_NN developed_VBD delayed_JJ clinical_JJ signs_NNS (_( from_IN day_NN 5_CD p.i._NN )_) ,_, with_IN an_DT LD50_NP of_IN 100_CD PFU_NP ,_, whereas_IN mice_NNS infected_VBN with_IN the_DT 2887A/91_JJ parent_NN virus_NN developed_VBD clinical_JJ signs_NNS from_IN day_NN 1_CD p.i._NN ,_, and_CC the_DT LD50_NP was_VBD 1_CD PFU_NN ._SENT A_DT more_RBR intriguing_JJ fact_NN is_VBZ that_IN EMCV_NP 30/87_CD and_CC strain_VB 2887A/91_JJ ,_, both_CC recent_JJ isolates_NNS from_IN pigs_NNS ,_, have_VBP 4-_CD to_TO 10-fold-shorter_JJ poly(C)_NN tracts_NNS than_IN the_DT older_JJR EMCVs_NP ,_, suggesting_VBG that_IN evolutionary_JJ pressure_NN may_MD favor_VB the_DT emergence_NN of_IN EMCV_NP strains_NNS with_IN shorter_JJR poly(C)_NN tracts_NNS ,_, at_IN least_JJS in_IN pigs_NNS ._SENT A_DT number_NN of_IN more_JJR recent_JJ EMCV_NP strains_NNS have_VBP been_VBN isolated_VBN from_IN pigs_NNS and_CC rodents_NNS ,_, but_CC their_PP$ genomic_JJ structures_NNS ,_, in_IN particular_RB the_DT lengths_NNS of_IN their_PP$ poly(C)_JJ tracts_NNS ,_, have_VBP not_RB been_VBN determined_VBN ._SENT It_PP was_VBD demonstrated_VBN previously_RB that_IN experimental_JJ infection_NN of_IN pigs_NNS with_IN EMCV_NP 30/87_CD resulted_VBD in_IN acute_JJ fatal_JJ cardiac_JJ failure_NN for_IN 16_CD %_NN of_IN the_DT pigs_NNS and_CC persistent_JJ infection_NN in_IN myocardial_JJ and_CC CNS_NP cells_NNS for_IN the_DT remaining_VBG 84_CD %_NN ._SENT In_IN addition_NN ,_, EMCV_NP 30/87_CD productively_RB infected_VBN primary_JJ human_JJ cardiomyocytes_NNS ,_, suggesting_VBG that_IN undetected_JJ EMCV_NP in_IN porcine_JJ neural_JJ or_CC myocardial_JJ tissues_NNS transplanted_VBN into_IN humans_NNS may_MD result_VB in_IN severe_JJ infection_NN in_IN recipients_NNS ._SENT The_DT studies_NNS described_VBN in_IN this_DT report_NN were_VBD also_RB undertaken_VBN in_IN order_NN to_TO determine_VB the_DT ability_NN of_IN EMCVs_NP to_TO cause_VB interspecies_NNS disease_NN outbreaks_NNS by_IN comparing_VBG the_DT pathogenesis_NN and_CC disease_NN phenotypes_NNS induced_VBN by_IN EMCV_NP 30/87_CD in_IN C57BL/6_NP mice_NNS ,_, pigs_NNS ,_, and_CC cynomolgus_NN macaques_NNS ._SENT Infection_NN of_IN mice_NNS ,_, pigs_NNS ,_, and_CC cynomolgus_NN macaques_NNS resulted_VBN in_IN similar_JJ EMCV_NP 30/87_CD pathogenesis_NN ,_, characterized_VBN by_IN generalized_VBN virus_NN distribution_NN followed_VBN by_IN localization_NN of_IN virus_NN in_IN the_DT myocardium_NN and_CC CNS_NP ,_, which_WDT were_VBD the_DT primary_JJ sites_NNS of_IN virus_NN replication_NN and_CC histopathologic_JJ changes_NNS in_IN the_DT three_CD animal_JJ species_NNS ._SENT Viral_JJ RNA_NP was_VBD detected_VBN in_IN the_DT blood_NN ,_, spleen_NN ,_, kidneys_NNS ,_, liver_NN ,_, heart_NN ,_, and_CC brain_NN in_IN 75_CD to100_NN %_NN of_IN infected_JJ macaques_NNS ,_, and_CC in_IN more_JJR than_IN 50_CD %_NN of_IN infected_JJ mice_NNS ,_, within_IN 7_CD days_NNS p.i._JJ Interestingly_NP ,_, the_DT virus_NN spread_NN was_VBD slower_JJR in_IN pigs_NNS ,_, requiring_VBG as_RB long_RB as_IN 21_CD days_NNS for_IN detection_NN of_IN viral_JJ RNA_NP in_IN all_PDT the_DT organs_NNS ._SENT The_DT most_RBS severe_JJ lesions_NNS (_( based_VBN on_IN the_DT extent_NN of_IN lymphocytic_JJ infiltration_NN and_CC the_DT number_NN of_IN lesions_NNS )_) were_VBD observed_VBN in_IN pigs_NNS ,_, followed_VBN by_IN mice_NNS ,_, with_IN macaques_NNS having_VBG the_DT least_JJS severe_JJ disease_NN ._SENT The_DT differences_NNS in_IN disease_NN phenotype_NN among_IN the_DT three_CD animal_NN species_NNS were_VBD intriguing_JJ ._SENT All_DT infected_JJ mice_NNS developed_VBD acute_JJ encephalitis_NN characterized_VBN by_IN paresis_NN and_CC flaccid_JJ paralysis_NN of_IN the_DT posterior_JJ limbs_NNS and_CC resulting_VBG in_IN death_NN from_IN acute_JJ respiratory_JJ failure_NN between_IN days_NNS 2_CD and_CC 7_CD p.i._NN In_IN contrast_NN ,_, a_DT small_JJ proportion_NN of_IN pigs_NNS (_( 16_CD %_NN )_) ,_, the_DT original_JJ host_NN of_IN the_DT virus_NN ,_, died_VBN from_IN sudden_JJ cardiac_JJ failure_NN 2_CD days_NNS after_IN infection_NN ,_, whereas_IN the_DT rest_NN of_IN the_DT animals_NNS remained_VBD overtly_RB asymptomatic_JJ for_IN as_RB long_JJ as_IN 90_CD days_NNS p.i._JJ ,_, despite_IN extensive_JJ myocardial_JJ and_CC CNS_NP histopathologic_JJ changes_NNS ._SENT All_DT EMCV_NP 30/87-infected_JJ macaques_NNS remained_VBD asymptomatic_JJ for_IN the_DT entire_JJ experimental_JJ period_NN (_( 45_CD days_NNS )_) ,_, despite_IN extensive_JJ myocardial_JJ pathological_JJ changes_NNS and_CC virus_NN persistence_NN in_IN more_JJR than_IN 50_CD %_NN of_IN the_DT animals_NNS ._SENT Although_IN limited_VBN to_TO mice_NNS only_JJ ,_, previous_JJ studies_NNS suggested_VBD that_IN EMCV_NP strains_NNS isolated_VBN from_IN pigs_NNS or_CC primates_NNS could_MD induce_VB severe_JJ disease_NN in_IN other_JJ animals_NNS ._SENT EMCV_NP R/45_NP ,_, isolated_VBN from_IN a_DT 5-year-old_JJ chimpanzee_NN suffering_NN from_IN acute_JJ fatal_JJ myocarditis_NN in_IN 1945_CD ,_, induced_VBN paralysis_NN of_IN the_DT hind_JJ legs_NNS and_CC interstitial_JJ myocarditis_NN in_IN mice_NNS ._SENT Mengo_NP virus_NN M/48_NP ,_, isolated_VBN from_IN the_DT cerebrospinal_JJ fluid_NN of_IN a_DT paralyzed_JJ rhesus_NN macaque_NN ,_, induced_VBN paralysis_NN ,_, characterized_VBN by_IN lesions_NNS in_IN brain_NN and_CC spinal_JJ cords_NNS ,_, and_CC myocarditis_NN in_IN mice_NNS ._SENT EMC-B/58_NP and_CC EMC_NP 